Figure 1.
The nomogram for predicting 1-, 3-, 5-year OS of HCC patients with MVI after treatment TACE combined with IMRT. TACE, transcatheter arterial chemoembolization; AFP, alpha fetoprotein; OS, overall survival; HCC, hepatocellular carcinoma; MVI, macrovascular invasion; IMRT, intensity modulated radiotherapy.